New research out of Michigan State University expands on current understanding of the brain chemical dopamine, finding that it plays a role in reducing the value of memories associated with rewards.
AusperBio’s AHB-137 breakthrough designation in China for CHB
AHB-137 is a new therapeutic option for patients with chronic hepatitis B. Credit: Peakstock/Shutterstock. AusperBio Therapeutics and Ausper Biopharma have gained breakthrough therapy designation (BTD)